Vaccine preventable diseases, vaccine hesitancy, and COVID-19: A role for the allergist/immunologist.
作者信息
Bellanti Joseph A, Settipane Russell A
出版信息
Allergy Asthma Proc. 2021 Sep 1;42(5):365-367. doi: 10.2500/aap.2021.42.210070.
Abstract
摘要
相似文献
1
Vaccine preventable diseases, vaccine hesitancy, and COVID-19: A role for the allergist/immunologist.疫苗可预防疾病、疫苗犹豫与2019冠状病毒病：过敏症专科医生/免疫学家的作用
Allergy Asthma Proc. 2021 Sep 1;42(5):365-367. doi: 10.2500/aap.2021.42.210070.
2
COVID-19 vaccines and vaccine hesitancy: Role of the allergist/immunologist in promotion of vaccine acceptance.COVID-19 疫苗和疫苗犹豫：过敏症/免疫学家在促进疫苗接种方面的作用。
Allergy Asthma Proc. 2021 Sep 9;42(5):386-394. doi: 10.2500/aap.2021.42.210063. Epub 2021 Aug 9.
3
The Role of the Allergist in Coronavirus Disease 2019 Vaccine Allergy Safety: A Pilot Study on a "Hub-and-Spoke" Model for Population-Wide Allergy Service.过敏专家在 2019 冠状病毒病疫苗过敏安全中的作用：一种针对人群过敏服务的“中心辐射”模式的初步研究。
Ann Allergy Asthma Immunol. 2022 Sep;129(3):308-312.e1. doi: 10.1016/j.anai.2022.05.011. Epub 2022 May 20.
4
Allergic Reactions to COVID-19 Vaccines: An Allergist's Perspective.对新冠疫苗的过敏反应：过敏症专科医生的观点
Acta Med Port. 2021 Mar 1;34(3):243. doi: 10.20344/amp.15803. Epub 2021 Feb 5.
5
COVID-19, health disparities, and what the allergist-immunologist can do.2019冠状病毒病、健康差异以及过敏与免疫专家能做些什么。
J Allergy Clin Immunol. 2021 Nov;148(5):1172-1175. doi: 10.1016/j.jaci.2021.09.017. Epub 2021 Sep 24.
6
Tracking COVID-19 vaccine hesitancy and logistical challenges: A machine learning approach.追踪新冠疫苗犹豫情绪及后勤挑战：一种机器学习方法。
PLoS One. 2021 Jun 2;16(6):e0252332. doi: 10.1371/journal.pone.0252332. eCollection 2021.
7
Medical experimentation and the roots of COVID-19 vaccine hesitancy among Indigenous Peoples in Canada.加拿大原住民中的医学实验与新冠疫苗犹豫情绪的根源
CMAJ. 2021 Mar 15;193(11):E381-E383. doi: 10.1503/cmaj.210112. Epub 2021 Feb 24.
8
Social media and vaccine hesitancy: new updates for the era of COVID-19 and globalized infectious diseases.社交媒体与疫苗犹豫：COVID-19 与全球化传染病时代的新动向。
Hum Vaccin Immunother. 2020 Nov 1;16(11):2586-2593. doi: 10.1080/21645515.2020.1780846. Epub 2020 Jul 21.
9
Addressing the elephant in the room: COVID-19 vaccine hesitancy in Black and Asian communities.直面房间里的大象：黑人和亚裔社区对新冠疫苗的犹豫态度。
Br J Gen Pract. 2021 Mar 26;71(705):170. doi: 10.3399/bjgp21X715433. Print 2021 Apr.
10
COVID-19 vaccine hesitancy: the five Cs to tackle behavioural and sociodemographic factors.新冠疫苗犹豫：应对行为和社会人口因素的五个C
J R Soc Med. 2021 Jun;114(6):295-298. doi: 10.1177/01410768211018951. Epub 2021 Jun 2.
引用本文的文献
1
Coronavirus disease 2019 vaccination uptake and hesitancy among Polish patients with inborn errors of immunity, autoinflammatory syndromes, and rheumatic diseases: A multicenter survey.2019 年冠状病毒病疫苗接种情况及波兰遗传性免疫缺陷、自身炎症性疾病和风湿性疾病患者的犹豫：一项多中心调查。
Front Immunol. 2022 Oct 6;13:1010899. doi: 10.3389/fimmu.2022.1010899. eCollection 2022.
2
Psychological impacts of coronavirus disease 2019 on people with asthma, allergic rhinitis, and food allergy.新型冠状病毒病 2019 对哮喘、过敏性鼻炎和食物过敏患者的心理影响。
Ann Allergy Asthma Immunol. 2022 Jul;129(1):52-61. doi: 10.1016/j.anai.2021.12.013. Epub 2021 Dec 29.
本文引用的文献
1
Does vitamin D deficiency in asthma affect clinical and functional parameters? A Turkish multicenter study.哮喘患者维生素 D 缺乏是否影响临床和功能参数？一项土耳其多中心研究。
Allergy Asthma Proc. 2021 Sep 1;42(5):e152-e158. doi: 10.2500/aap.2021.42.210056.
2
Tropomyosin: A panallergen that causes a worldwide allergic problem.原肌球蛋白：一种引起全球性过敏问题的泛过敏原。
Allergy Asthma Proc. 2021 Sep 1;42(5):e145-e151. doi: 10.2500/aap.2021.42.210057.
3
Food-induced anaphylaxis in early childhood and factors associated with its severity.婴幼儿食物过敏及其严重程度相关因素。
Allergy Asthma Proc. 2021 Sep 1;42(5):e135-e144. doi: 10.2500/aap.2021.42.210051.
4
Bronchial provocation test measured by using the forced oscillation technique to assess airway responsiveness.采用强迫振荡技术测量支气管激发试验评估气道反应性。
Allergy Asthma Proc. 2021 Sep 1;42(5):e127-e134. doi: 10.2500/aap.2021.42.210044.
5
Caregiver perceptions and attitudes associated with oral immunotherapy on social media.社交媒体上与口服免疫治疗相关的照顾者认知和态度。
Allergy Asthma Proc. 2021 Sep 1;42(5):432-438. doi: 10.2500/aap.2021.42.210050.
6
Efficacy and safety of crisaborole in patients with mild-to-moderate atopic dermatitis and other atopic comorbidities.在患有轻度至中度特应性皮炎和其他特应性合并症的患者中，crisaborole 的疗效和安全性。
Allergy Asthma Proc. 2021 Sep 1;42(5):425-431. doi: 10.2500/aap.2021.42.210064.
7
Impact of type 2 targeting biologics on acute exacerbations of chronic rhinosinusitis.2 型靶向生物制剂对慢性鼻-鼻窦炎急性加重的影响。
Allergy Asthma Proc. 2021 Sep 1;42(5):417-424. doi: 10.2500/aap.2021.42.210058.
8
Effect of COVID-19 on hereditary angioedema activity and quality of life.COVID-19 对遗传性血管性水肿活动和生活质量的影响。
Allergy Asthma Proc. 2021 Sep 1;42(5):403-408. doi: 10.2500/aap.2021.42.210066.
9
Sustained decrease in pediatric asthma emergency visits during the first year of the COVID-19 pandemic.COVID-19 大流行第一年，儿科哮喘急诊就诊人数持续减少。
Allergy Asthma Proc. 2021 Sep 1;42(5):400-402. doi: 10.2500/aap.2021.42.210059.
10
Allergic reactions and adverse events associated with administration of mRNA-based vaccines. A health-care system experience.与基于 mRNA 的疫苗接种相关的过敏反应和不良事件。医疗保健系统的经验。
Allergy Asthma Proc. 2021 Sep 1;42(5):395-399. doi: 10.2500/aap.2021.42.210069.
Zotero 插件